JYSB1700205 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2017-11-23 | 默沙东研发(中国)有限公司 | MSD R&D (China) Co Ltd;Merck Sharp & Dohme Ltd;Msd International GmbH | Filed | 2017-12-04 | view |
CXSL1700150 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(13) | New Drug Application | 2018-03-30 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | Certificate Issued | 2018-07-06 | view |
CXSS2000038 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(13) | New Drug Application | 2020-07-04 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | Certificate Issued | 2021-08-04 | view |
CXSB0700094 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2007-10-09 | 长春海伯尔生物技术有限责任公司 | ChangChun Heber Biological Technology Co Ltd | Certificate Issued | 2009-11-11 | view |
CYSB1000222 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-01-06 | 长春海伯尔生物技术有限责任公司 | ChangChun Heber Biological Technology Co Ltd | Certificate Issued | 2011-10-11 | view |
CYSB1000223 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-01-06 | 长春海伯尔生物技术有限责任公司 | ChangChun Heber Biological Technology Co Ltd | Certificate Issued | 2011-10-11 | view |
CYSB1000630 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-06-01 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-07-24 | view |
CYSB2000115 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
CYSB1200063 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2012-03-23 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2013-04-23 | view |
CXSL1600024 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(14) | New Drug Application | 2016-03-30 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2017-02-13 | view |
CYSB2000118 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
CYSB1500472 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2016-06-06 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2016-11-17 | view |
CXSL1100079 | 聚乙二醇化重组人干扰素α2b注射液 | | Injection | Biological Products(9) | New Drug Application | 2012-02-02 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-05-16 | view |
CXSL1600022 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(14) | New Drug Application | 2016-03-30 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2017-02-13 | view |
CXSB0800043 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-10-23 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2009-04-08 | view |
CYSB1000629 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2011-05-24 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2014-07-24 | view |
CYSB1500473 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2016-06-06 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2016-11-17 | view |
CXSB0800044 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2008-10-23 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2009-04-08 | view |
CYSB1700104 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2017-06-14 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2021-07-28 | view |
CYSB2000117 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程(集团)股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |